Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Critics call for transparency in a federal hospital funding stream By HPN Staff Key Points The federal 340B program, originally designed to help safety-net hospitals fund uncompensated care, has grown dramatically and now faces scrut... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Rural hospitals face greater challenges By Tom Morris This is a lightly edited excerpt of testimony recently provided to the U.S. House of Representatives’ Energy and Commerce Health Subcommittee during the hearing “Legislative Pro... Read more Two companies control majority of dialysis market, study says By HPN Staff Just two healthcare firms account for almost 80% of the market for dialysis treatments, which are a major source of spending across both the Medicare and Medicaid programs, accor... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more 1 2 3 MOST VIEWED 1 Telehealth shutdown makes doctors’ visits more difficult for some 2 Bipartisan coalition aims to prevent health premium spike for the self-employed 3 Why Ohio needs the Respiratory Care Interstate Compact 4 Acupuncture shows promise for back pain in older adults, study finds DONATE
Critics call for transparency in a federal hospital funding stream By HPN Staff Key Points The federal 340B program, originally designed to help safety-net hospitals fund uncompensated care, has grown dramatically and now faces scrut... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Rural hospitals face greater challenges By Tom Morris This is a lightly edited excerpt of testimony recently provided to the U.S. House of Representatives’ Energy and Commerce Health Subcommittee during the hearing “Legislative Pro... Read more Two companies control majority of dialysis market, study says By HPN Staff Just two healthcare firms account for almost 80% of the market for dialysis treatments, which are a major source of spending across both the Medicare and Medicaid programs, accor... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more 1 2 3
Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Rural hospitals face greater challenges By Tom Morris This is a lightly edited excerpt of testimony recently provided to the U.S. House of Representatives’ Energy and Commerce Health Subcommittee during the hearing “Legislative Pro... Read more Two companies control majority of dialysis market, study says By HPN Staff Just two healthcare firms account for almost 80% of the market for dialysis treatments, which are a major source of spending across both the Medicare and Medicaid programs, accor... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more 1 2 3
New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Rural hospitals face greater challenges By Tom Morris This is a lightly edited excerpt of testimony recently provided to the U.S. House of Representatives’ Energy and Commerce Health Subcommittee during the hearing “Legislative Pro... Read more Two companies control majority of dialysis market, study says By HPN Staff Just two healthcare firms account for almost 80% of the market for dialysis treatments, which are a major source of spending across both the Medicare and Medicaid programs, accor... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more 1 2 3
Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Rural hospitals face greater challenges By Tom Morris This is a lightly edited excerpt of testimony recently provided to the U.S. House of Representatives’ Energy and Commerce Health Subcommittee during the hearing “Legislative Pro... Read more Two companies control majority of dialysis market, study says By HPN Staff Just two healthcare firms account for almost 80% of the market for dialysis treatments, which are a major source of spending across both the Medicare and Medicaid programs, accor... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more 1 2 3
Pharma advances non-opioid pain drugs By HPN Staff The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addic... Read more Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Rural hospitals face greater challenges By Tom Morris This is a lightly edited excerpt of testimony recently provided to the U.S. House of Representatives’ Energy and Commerce Health Subcommittee during the hearing “Legislative Pro... Read more Two companies control majority of dialysis market, study says By HPN Staff Just two healthcare firms account for almost 80% of the market for dialysis treatments, which are a major source of spending across both the Medicare and Medicaid programs, accor... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more 1 2 3
Feds eye tighter restrictions on pharma ads By HPN Staff The Trump administration, led by Secretary of Health and Human Services Robert F. Kennedy Jr., is considering proposals to impose restrictions on pharmaceutical advertisements. ... Read more Rural hospitals face greater challenges By Tom Morris This is a lightly edited excerpt of testimony recently provided to the U.S. House of Representatives’ Energy and Commerce Health Subcommittee during the hearing “Legislative Pro... Read more Two companies control majority of dialysis market, study says By HPN Staff Just two healthcare firms account for almost 80% of the market for dialysis treatments, which are a major source of spending across both the Medicare and Medicaid programs, accor... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more 1 2 3
Rural hospitals face greater challenges By Tom Morris This is a lightly edited excerpt of testimony recently provided to the U.S. House of Representatives’ Energy and Commerce Health Subcommittee during the hearing “Legislative Pro... Read more Two companies control majority of dialysis market, study says By HPN Staff Just two healthcare firms account for almost 80% of the market for dialysis treatments, which are a major source of spending across both the Medicare and Medicaid programs, accor... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more 1 2 3
Two companies control majority of dialysis market, study says By HPN Staff Just two healthcare firms account for almost 80% of the market for dialysis treatments, which are a major source of spending across both the Medicare and Medicaid programs, accor... Read more Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more
Non-opioid pain treatment alternatives gaining public and private traction By HPN Staff In the fight to end the nation’s opioid epidemic, researchers and investors in the pain-management field are making headway in developing alternative options for treating pain. L... Read more
